Literature DB >> 16594130

Microvascular oxygenation and oxidative stress during postischemic reperfusion. PO2, ROS, and NO during reperfusion.

Silvia Bertuglia, Andrea Giusti.   

Abstract

Increased formation of ROS on reperfusion after ischemia underlies ischemia reperfusion (I/R) damage. We measured, in real time, both oxygen tension in microvessels and tissue and oxidant stress during postischemic reperfusion in hamster cheek pouch microcirculation. We measured PO2 by using phosphorescence quenching microscopy and oxygen radical species (ROS) production in the systemic blood. We evaluated the effects of a NOS inhibitor (L-NMMA) and superoxide dismutase (SOD) on the oxidative stress during reperfusion. Microvascular injury was assessed by measuring diameter change, the perfused capillary length (PCL), and leukocyte adhesion. Our findings demonstrate that early reperfusion is characterized by low concentration of oxygen linked to increased production of ROS. After this initial transience in arterioles, the oxygen tension and production of ROS return to normal after reperfusion, while the blood flow and capillary perfusion decrease. The early increased ROS production, in turn, may impair oxygen consumption by endothelial cells, thus further promoting activation of oxygen to ROS. This event is substantiated by the finding that treatment with SOD maintains ROS at normal levels, which, in turn, should be effective to increase the production of endothelial NO. Conversely, a decrease in NO levels led to decreased ROS production during early reperfusion, which increased later during reperfusion, ultimately causing vasoconstriction and greatly increasing venular leukocyte adhesion on postcapillary venules during hypoxic conditions. Therefore, low-flow hypoxia is primarily responsible for vascular endothelial damage during reperfusion through changes in ROS and NO production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16594130     DOI: 10.1007/0-387-26206-7_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

Review 1.  The physics of oxygen delivery: facts and controversies.

Authors:  Amy G Tsai; Pedro Cabrales; Marcos Intaglietta
Journal:  Antioxid Redox Signal       Date:  2010-03-15       Impact factor: 8.401

Review 2.  Potential implication of the chemical properties and bioactivity of nitrone spin traps for therapeutics.

Authors:  Frederick A Villamena; Amlan Das; Kevin M Nash
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

3.  Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function.

Authors:  Mahmoud M El-Mas; Hanan M El-Gowelli; Khaled S Abd-Elrahman; Evan I Saad; Abdel-Galil A Abdel-Galil; Abdel A Abdel-Rahman
Journal:  Biochem Pharmacol       Date:  2010-11-27       Impact factor: 5.858

4.  Early iNOS impairment and late eNOS enhancement during reperfusion following 2.49 MHz continuous ultrasound exposure after ischemia.

Authors:  C Makena Hightower; Marcos Intaglietta
Journal:  Ultrason Sonochem       Date:  2008-05-24       Impact factor: 7.491

Review 5.  Renal hypoxia and dysoxia after reperfusion of the ischemic kidney.

Authors:  Matthieu Legrand; Egbert G Mik; Tanja Johannes; Didier Payen; Can Ince
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

6.  Selected oxidative stress markers in gynecological laparoscopy.

Authors:  Jacek Koźlik; Joanna Przybyłowska; Kinga Mikrut; Wioletta A Żukiewicz-Sobczak; Jacek Zwoliński; Jacek Piątek; Paweł Sobczak
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-12-04       Impact factor: 1.195

7.  Therapeutic Target and Cell-signal Communication of Chlorpromazine and Promethazine in Attenuating Blood-Brain Barrier Disruption after Ischemic Stroke.

Authors:  Fengwu Li; Xiaokun Geng; James Yip; Yuchuan Ding
Journal:  Cell Transplant       Date:  2018-12-20       Impact factor: 4.064

8.  Estradiol reduces ferrous citrate complex-induced NOS2 up-regulation in cerebral endothelial cells by interfering the nuclear factor kappa B transactivation through an estrogen receptor β-mediated pathway.

Authors:  Li-Ching Chen; Wen-Sen Lee
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.